65,437 trials
Restless Legs Syndrome (RLS)
Primary: International Restless Legs Syndrome (IRLS) Total Score — -8.9; -4.0 Scores on a scale
Alzheimer's Disease
Primary: Number of Participants Who Discontinued From the Study Due to Any Reason During the Core Phase of the Study — 11; 10 Participants
Heart Failure
Primary: Number of Participants With First Occurrence of Cardiovascular (CV) Mortality or Hospitalization Due to Heart Failure (HF) (Adjudicated): Up to Cut-off Date — 249; 356…
Chronic Kidney Failure
Primary: Ease of Use: Priming Blood Side — 139; 13; 13; 80 Number of Dialyzers
Healthy
Primary: AUCτ,ss (Fed Conditions) — 33.7; 32.3 ng·h/mL
Hepatitis B
Primary: Number of Subjects With an Anamnestic Response to a Challenge Dose of Hepatitis B Virus (HBV) Vaccine as Measured by Enzyme-Linked Immunosorbent Assay (ELISA). — 8; 13…
Bradycardia
Primary: Performance of Activities of Daily Living Tests (6-minute Walk and Sweep) — 19.28; 18.09; 18.05 repetitions — p=0.004
HC-BPPV
Primary: Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial — 38; 33; 17 participants
Breast Cancer · Prostate Cancer · Bone Neoplasms
Primary: Percentage Change From Baseline in Serum Beta C-terminal Cross-linking Telopeptide of Type I Collagen (betaCTX) at Week 4 — -71.1; -68.4 Percentage change in betaCTX
Bipolar I Disorder
Primary: Percentage of Participants With Adverse Events Leading to Discontinuation — 7.1; 12.0; 40.0 percentage of participants
Type 2 Diabetes
Primary: Area Under the Curve (AUC(0-t)) for Sitagliptin — 1570; 1590; 1520; 1600 hr*ng/mL
Myopia
Primary: Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion. — 77; 15; 84 participants
Moderate to Severe Hypertension
Primary: Mean Sitting Systolic Blood Pressure (msSBP) — -37.72; -30.63 mm Hg
Other Surgical Procedures
Primary: Number of Participants With Complete Sensory Block — 38; 39; 39 participants — p=1
Hepatitis C
Primary: Virological Response (Intention to Treat) — 19; 21; 7; 2 participants